Generic Formulation Products
Therapy Area 
Dosage Form
Dossier Status
Filed
Oral
Linagliptin
Anti-Diabetic
- 5 mg
Under Development
Oral
Sitagliptin HCL + Metformin
Anti-Diabetic
- 50 + 500
- 50 + 850
Filed
Oral
Linagliptin + Metformin
Anti-Diabetic
- 2.5 mg/500 mg
- 2.5 mg/850 mg
- 2.5 mg/1000 mg
Filed
Oral
Sitagliptin HCL
Anti-Diabetic
- 25
- 50
- 100 mg
Filed
Oral
Sitagliptin Phosphate
Anti-Diabetic
- 25
- 50 and 100 mg
Filed
Oral
Sitagliptin Phosphate + Metformin
Anti-Diabetic
- 50 + 500
- 50 + 1000 mg
Under Development
Injectable
Liraglutide
Anti-Diabetic
- 6 mg/ml (3 ml)
Under Development
Injectable
Liraglutide
Anti-Obesity
- 6 mg/ml (3 ml)
- ...